Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Alembic

Sector: Healthcare | Industry: Drugs & Pharma
R 49.00 -0.20  | -0.41% 24.05% 32.61 1,258.23
NSE Price: Oct 23, 15:53 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 23, 15:53 49.00 -0.20 -0.41% 48.55 49.20 133,406 47.80 - 50.25
BSE Oct 23, 2019 49.00 -0.15 -0.31% 47.60 49.15 16,140 47.50 - 50.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 194,606 P/B: 3.04 NSE Code: ALEMBICLTD
52-Week Range: R 33.45 - 56.00 Dividend Yield: 0.41% BSE Code: 506235
TTM EPS: R 1.50 Book Value: R 16.14 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Alembic 2.51 -4.95 15.02 23.89 4.44 0.97 7.79
S&P BSE Small Cap* -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare* -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of BSE's price.
As on Oct 23, 2019
*As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -1.19 -0.98 -
Net Profit -1.67 18.45 -
EPS 35.97 -1.87 -
Book Value 15.75 16.10 -
Average
Operating Margin 38.38 34.13 30.15
Net Margin 26.68 22.62 19.65
Return on Networth 3.58 3.66 4.05
Return on Investment 3.91 3.83 3.82
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 2.80 -41.53 2.80
Operating Profit -49.12 -69.71 -49.12
Net Profit -62.56 -78.44 -62.56
EPS -33.77 9.73 -33.77
TTM
Revenue - - -
Operating Profit - - -
Net Profit - - -
EPS - - -
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Alembic 1,258.23 109.22 38.58 27.78 3.58 3.04 32.61
Astrazeneca Pharma India 6,332.38 771.42 69.56 8.84 20.03 19.78 91.03
Eris Lifesciences 5,764.14 1,005.70 303.64 29.29 28.96 4.67 18.99
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 27, 2019 Nirayu Pvt Ltd  Buy Market 259,397 55.00 142.67
Sep 25, 2019 GALLUP TRUST  Buy Market 100 51.75 0.05
Sep 25, 2019 GRACE STAR TRUST  Buy Market 100 51.75 0.05
Sep 25, 2019 LAKSH TRUST  Buy Market 100 51.75 0.05
Sep 25, 2019 Nirayu Pvt Ltd  Buy Market 183,111 51.75 94.76
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
SBI Mutual Fund 5.836 5.710 5.697 5.550 5.394
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Alembic Ltd.

Address: Alembic Road, Vadodara, Gujarat - 390003 | Phone: 0265-2280550 / 2280880 | Fax: 0265-2282506

Email: [email protected]

Website: www.alembiclimited.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: B-102 & 103, Shangrila Complex, First Floor, Opp. HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara 390020, B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota

Essential checks
Altman Z-Score
14.69
Piotroski F-Score
4
Modified C-Score
3
5-Years Price to Earnings
32.61
5-Years Price to Book
3.04
Earnings Yield
EBIT / Enterprise value
3.43%
PEG
Price / Earnings to growth ratio
4.24
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,531.95 +4.97%
Caplin Point Laboratories R382.95 -1.24%
Eris Lifesciences R421.25 -0.98%
FDC R159.30 -1.03%
JB Chemicals & Pharma R355.00 -1.33%
Laurus Labs R348.00 +1.84%
Strides Pharma Science R343.50 -2.07%
Sun Pharma Adv. Research R129.30 -2.49%
Suven Life Sciences R288.40 +0.61%
Wockhardt R269.80 -1.96%
As on Oct 23, 15:59